Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Metformin hydrochloride news
All news on
Metformin hydrochloride
(also known as
Glucophage
,
Glucophage XR
,
Fortamet
, and
Riomet
): plants, production capacities, investments and involved companies.
2 February 2026
Novo Nordisk Announces REIMAGINE 2 Trial Results
CagriSema showed superior HbA1c reduction and weight loss over semaglutide in a 68-week trial with type 2 diabetes patients inadequately controlled with metformin.
25 November 2025
Novo Nordisk Reports Phase 2 Success with Amycretin in Type 2 Diabetes
Amycretin shows significant HbA1c reduction and weight loss in type 2 diabetes patients, with a safe profile. Phase 3 trials planned for 2026.
Who will be producing Metformin hydrochloride in the future?
Find out with
chemXplore Analytics
Learn more